Genesee Valley Trust’s AbbVie ABBV Stock Holding History

Genesee Valley Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$432K	Hold	3,726	–	–	0.18%	95
2017 Q4	$360K	Buy	3,726 +386	+12%	+$36.4K	0.15%	132
2017 Q3	$297K	Hold	3,340	–	–	0.12%	153
2017 Q2	$242K	Hold	3,340	–	–	0.1%	175
2017 Q1	$217	Hold	3,340	–	–	0.15%	210
2016 Q4	$209	Hold	3,340	–	–	0.15%	213
2016 Q3	$211K	Hold	3,340	–	–	0.13%	236
2016 Q2	$207K	Sell	3,340 -4,802	-59%	-$293K	0.13%	217
2016 Q1	$465K	Hold	8,142	–	–	0.31%	105
2015 Q4	$482K	Sell	8,142 -213	-3%	-$12.3K	0.32%	109
2015 Q3	$455K	Hold	8,355	–	–	0.3%	115
2015 Q2	$561K	Buy	8,355 +1,053	+14%	+$68.7K	0.36%	81
2015 Q1	$427K	Buy	7,302 +3,962	+119%	+$239K	0.26%	103
2014 Q4	$219K	Buy	+3,340	New	+$211K	0.14%	235

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Genesee Valley Trust's ABBV Position: Q1 2018 in Review

Genesee Valley Trust held its AbbVie (ABBV) position steady in Q1 2018 at 3,726 shares worth $432K. The position accounts for 0.18% of the portfolio, ranked #95.

Genesee Valley Trust first reported a position in ABBV in Q4 2014 and has held it in 14 quarters since. The position peaked at $561K in Q2 2015. 2,015 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Genesee Valley Trust held 3,726 shares of AbbVie worth $432K as of Q1 2018.
Genesee Valley Trust left its AbbVie share count unchanged in Q1 2018.
AbbVie made up 0.18% of Genesee Valley Trust's portfolio in Q1 2018, its #95 holding.
Genesee Valley Trust first reported a position in AbbVie in Q4 2014 and has held it in 14 quarters since.
Genesee Valley Trust's AbbVie position peaked at $561K in Q2 2015.
2,015 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Genesee Valley Trust's 13F filing for Q1 2018, filed 3 Apr 2018.